Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Purdue pharma | History Defined

Two charities that received £1.1m from Sackler Trust kept anonymous to prevent ‘serious prejudice’

British charitable trust that draws on OxyContin-maker fortune says it exempted names to protect reputations

The Guardian - UK

Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers

Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers

A judge is set to explain why he's approving a plan for OxyContin maker Purdue Pharma to settle thousands of lawsuits over the toll of opioids

The Independent UK

Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know

Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know

OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market

Purdue Pharma won court approval to exit bankruptcy, ending six years of litigation over its multibillion-dollar opioid settlement and the Sackler family’s liability releases. Purdue's Chapter 11 plan provides an estimated $7.4 billion to address nationwide opioid harm.

Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections

The company that makes OxyContin, members of the Sackler family who own it and many groups that sued over its role in the opioid crisis are asking a judge to approve a settlement plan

The Independent UK

Purdue Pharma plan moves forward despite challenge from opioid victim

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

The Guardian - US

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

inkl

Read news from The Economist, FT, and more,
with one subscription

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved

The Independent UK

New York AG Blasts Sackler Family While Announcing $7.4 Billion Purdue Pharma Settlement: 'No Amount of Money Will Ever Fully Repair The Damage They Caused'

New York AG Blasts Sackler Family While Announcing $7.4 Billion Purdue Pharma Settlement: 'No Amount of Money Will Ever Fully Repair The Damage They Caused'

New York's AG shared news of The Sackler family and Purdue Pharma settlement, while stating "no amount of money" could reverse the destruction caused.

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller

The Independent UK

Sacklers, Purdue To Pay $7.4 Bn Over Opioid Crisis

Sacklers, Purdue To Pay $7.4 Bn Over Opioid Crisis

Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

Purdue Pharma and Sacklers reach new $7.4bn settlement over opioids crisis

Settlement resolves thousands of lawsuits alleging Oxycontin caused addiction crisis

The Guardian - US

Ex-McKinsey partner pleads guilty to destroying records on opioids

Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales

International Business Times

McKinsey To Pay $650 Mn To Settle US Criminal Case On Opioids

Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis, officials announced Friday.

The Guardian - US

McKinsey to pay $650m to resolve US investigation into opioid crisis role

Consultancy giant agrees to two criminal counts, including for conspiring with drug manufacturers, in DoJ settlement

Get all your
news in one place.

100's of premium titles.
One news app.

Mckinsey To Pay 0 Million In Purdue Pharma Settlement

McKinsey & Company agrees to pay 0 million in settlement for its role in Purdue Pharma's opioid crisis, impacting addiction and overdose prevention efforts.

The Independent UK

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids work

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia

No, Not That David Sackler; No, Not That State Law

Law students: Take that Choice of Law (often called Conflicts of Laws) course your law school offers; it can be tremendously important.

International Business Times

J&J Gets Support For $6.5B Baby Talc Settlement Amid Third Bankruptcy Bid: Report

The healthcare giant faces lawsuits from 61,000 claimants who allege that asbestos contamination in its talc products led to ovarian and other cancers.

The Guardian - US

Harvard declines to remove Sackler name from museum and campus building

Committee rejects student denaming proposal despite role of Sackler-owned Purdue Pharma in US opioid epidemic

The Independent UK

Harvard rebuffs protests and won't remove Sackler name from two buildings

Harvard University has decided against removing the name of a family whose company makes the powerful painkiller OxyContin, despite protest from parents whose children fatally overdosed

Purdue Pharma Faces Challenges In Opioid Lawsuit Settlement

Purdue Pharma seeks new settlement after Supreme Court rejection in opioid crisis fallout.

1 2 3 4 5

People

Matthew Platkin

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Harvard University

the Wall Street Journal

the Department of Justice

the US Supreme Court

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

363,538 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play